Accounting reportsPreviously
|
Name | APTEKA N1, OOO |
|---|
INN | 7810466917 |
|---|
KPP | 784001001 |
|---|
OGRN | 1137847252630 |
|---|
OKPO | 27475317 |
|---|
Address | 191025, G.sankt-peterburg, ul. Stremyannaya, d. D. 22/3, of. POMESCH. 3N |
|---|
Phone | 611-07-38 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 46.18.1 | Additional activity | Agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | All types of activities | | 46.46.1 | Additional activity | Wholesale of furniture, carpets and lighting equipment | | 46.46.2 | Additional activity | Wholesale of medical and orthopedic goods, dental and laboratory supplies | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores |
Registration date | 04.07.2013 |
|---|
|
APTEKA N1, OOO (Saint Petersburg; INN 7810466917) was registered on 4 Jul 2013. The company's authorized capital as of July 1, 2012 was 20000 rub. Principal activities of APTEKA N1, OOO: retailing drugs in specialized stores (pharmacies) (47.73), agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents (46.18.1), wholesale of pharmaceutical goods (46.46). |
Economic indicators2024
Net profit (RAS) of APTEKA N1, OOO over 2024 was the same as in 2023 reaching 23.63 million RUB, the company informed. Revenue increased in the accounting period by 5.70% to 139.51 million RUB from 131.99 million RUB over 2023; cost of goods sold grew by 7.99% to 91.50 million RUB from 84.73 million RUB; sales profit fell by 1.49% to 26.68 million RUB from 27.08 million RUB. 2023
Net profit (RAS) of APTEKA N1, OOO grew over 2023 2.07 times to 23.37 million RUB from 11.30 million RUB over 2022, the company informed. Revenue increased in the accounting period by 28.92% to 131.79 million RUB from 102.23 million RUB over 2022; cost of goods sold grew by 24.66% to 84.69 million RUB from 67.93 million RUB; sales profit went up 1.67 times to 26.93 million RUB from 16.16 million RUB. 2022
Net profit (RAS) of APTEKA N1, OOO grew over 2022 by 39.15% to 11.30 million RUB from 8.12 million RUB over 2021, the company informed. Revenue increased in the accounting period by 21.33% to 102.23 million RUB from 84.26 million RUB over 2021; cost of goods sold grew by 16.50% to 67.93 million RUB from 58.31 million RUB; sales profit went up by 4.43% to 16.16 million RUB from 15.48 million RUB. 2021
Net profit (RAS) of APTEKA N1, OOO dropped in 2021 by 36.86% to 8.12 million RUB from 12.86 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 4.89% to 84.26 million RUB from 80.33 million RUB over 2020; cost of goods sold grew by 4.97% to 58.31 million RUB from 55.55 million RUB; sales profit went up by 6.50% to 15.48 million RUB from 14.53 million RUB. 2020
Net profit (RAS) of APTEKA N1, OOO grew over 2020 1.66 times to 12.86 million RUB from 7.77 million RUB over 2019, the company informed. Revenue increased in the accounting period by 38.79% to 80.33 million RUB from 57.88 million RUB over 2019; cost of goods sold grew by 38.98% to 55.55 million RUB from 39.97 million RUB; sales profit went up 1.69 times to 14.53 million RUB from 8.57 million RUB. 2019
Net profit (RAS) of APTEKA N1, OOO grew over 2019 1.80 times to 7.83 million RUB from 4.34 million RUB over 2018, the company informed. Revenue increased in the accounting period 1.65 times to 57.90 million RUB from 35.18 million RUB over 2018; cost of goods sold grew 1.71 times to 39.91 million RUB from 23.30 million RUB; sales profit went up 1.73 times to 8.65 million RUB from 5.00 million RUB. 2018
Net profit (RAS) of APTEKA N1, OOO grew over 2018 by 25.86% to 5.17 million RUB from 4.11 million RUB over 2017, the company informed. Revenue increased in the accounting period by 2.73% to 35.19 million RUB from 34.25 million RUB over 2017; cost of goods sold remained at the same level amounting to 22.47 million RUB compared to 22.51 million RUB; sales profit went up by 29.16% to 5.84 million RUB from 4.52 million RUB. 2017
Net profit (RAS) of APTEKA N1, OOO dropped in 2017 by 6.41% to 4.11 million RUB from 4.39 million RUB over the same period in 2016, the company informed. Revenue increased in the accounting period by 17.65% to 34.25 million RUB from 29.11 million RUB over 2016; cost of goods sold grew by 17.06% to 22.51 million RUB from 19.23 million RUB; sales profit fell by 8.19% to 4.52 million RUB from 4.92 million RUB. 2016
Net profit (RAS) of APTEKA N1, OOO grew over 2016 by 30.42% to 4.43 million RUB from 3.40 million RUB over 2015, the company informed. Revenue increased in the accounting period by 25.60% to 29.11 million RUB from 23.18 million RUB over 2015; cost of goods sold grew by 25.87% to 19.23 million RUB from 15.28 million RUB; sales profit went up by 34.86% to 4.97 million RUB from 3.69 million RUB. 2014
Net profit (RAS) of APTEKA N1, OOO made up 60.00 thousand RUB over 2014 compared to net loss of 641.00 thousand RUB over 2013, the company informed. Revenue increased in the accounting period 158.39 times to 19.64 million RUB from 124.00 thousand RUB over 2013; cost of goods sold grew 155.29 times to 13.04 million RUB from 84.00 thousand RUB; sales profit made up 468.00 thousand RUB compared to sales loss of 517.00 thousand RUB. 2013
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|